Literature DB >> 22071118

Ethnic-specific meta-analyses of association between the OPRM1 A118G polymorphism and alcohol dependence among Asians and Caucasians.

Dingyan Chen1, Li Liu, Yang Xiao, Yuehua Peng, Chengwu Yang, Zengzhen Wang.   

Abstract

BACKGROUND: Many studies have investigated the association between the OPRM1 A118G polymorphism (rs1799971) and alcohol dependence, but the results were inconsistent. To better understand this relationship, ethnicity-specific meta-analyses were conducted.
METHODS: We retrieved all eligible studies published up to April 12, 2011 from the PubMed/MEDLINE, EMBASE, and ISI Web of Science databases. Ethnicity-specific meta-analyses were performed using either fixed- or random-effect models as appropriate.
RESULTS: Twelve independent studies with 1900 cases and 2382 controls were included. Five studies were conducted in Asians and seven in Caucasians. Ethnicity-specific meta-analyses revealed that the A118G polymorphism was significantly associated with alcohol dependence risk in Asians (GA vs. AA: odds ratio [OR], 1.73; 95% confidence interval [CI], 1.33-2.25; GA+GG vs. AA: OR, 1.57; 95% CI, 1.22-2.02), but not in Caucasians (GA vs. AA: OR, 1.05; 95% CI, 0.75-1.49; GA+GG vs. AA: OR, 1.11; 95% CI, 0.79-1.55).
CONCLUSIONS: The OPRM1 A118G polymorphism may contribute to the susceptibility of alcohol dependence in Asians but not in Caucasians.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22071118     DOI: 10.1016/j.drugalcdep.2011.10.012

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  27 in total

Review 1.  Pharmacogenetics of OPRM1.

Authors:  Richard C Crist; Wade H Berrettini
Journal:  Pharmacol Biochem Behav       Date:  2013-11-05       Impact factor: 3.533

2.  Association between Opioid Receptor mu 1 (OPRM1) Gene Polymorphisms and Tobacco and Alcohol Consumption in a Spanish Population.

Authors:  Francesc Francès; Olga Portolés; Ana Castelló; Jose Antonio Costa; Fernando Verdú
Journal:  Bosn J Basic Med Sci       Date:  2015-04-25       Impact factor: 3.363

3.  A cis-eQTL in OPRM1 is Associated with Subjective Response to Alcohol and Alcohol Use.

Authors:  Jacqueline M Otto; Ian R Gizer; Joseph D Deak; Kimberly A Fleming; Bruce D Bartholow
Journal:  Alcohol Clin Exp Res       Date:  2017-04-10       Impact factor: 3.455

4.  Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts.

Authors:  Tae-Hwi Schwantes-An; Juan Zhang; Li-Shiun Chen; Sarah M Hartz; Robert C Culverhouse; Xiangning Chen; Hilary Coon; Josef Frank; Helen M Kamens; Bettina Konte; Leena Kovanen; Antti Latvala; Lisa N Legrand; Brion S Maher; Whitney E Melroy; Elliot C Nelson; Mark W Reid; Jason D Robinson; Pei-Hong Shen; Bao-Zhu Yang; Judy A Andrews; Paul Aveyard; Olga Beltcheva; Sandra A Brown; Dale S Cannon; Sven Cichon; Robin P Corley; Norbert Dahmen; Louisa Degenhardt; Tatiana Foroud; Wolfgang Gaebel; Ina Giegling; Stephen J Glatt; Richard A Grucza; Jill Hardin; Annette M Hartmann; Andrew C Heath; Stefan Herms; Colin A Hodgkinson; Per Hoffmann; Hyman Hops; David Huizinga; Marcus Ising; Eric O Johnson; Elaine Johnstone; Radka P Kaneva; Kenneth S Kendler; Falk Kiefer; Henry R Kranzler; Ken S Krauter; Orna Levran; Susanne Lucae; Michael T Lynskey; Wolfgang Maier; Karl Mann; Nicholas G Martin; Manuel Mattheisen; Grant W Montgomery; Bertram Müller-Myhsok; Michael F Murphy; Michael C Neale; Momchil A Nikolov; Denise Nishita; Markus M Nöthen; John Nurnberger; Timo Partonen; Michele L Pergadia; Maureen Reynolds; Monika Ridinger; Richard J Rose; Noora Rouvinen-Lagerström; Norbert Scherbaum; Christine Schmäl; Michael Soyka; Michael C Stallings; Michael Steffens; Jens Treutlein; Ming Tsuang; Tamara L Wall; Norbert Wodarz; Vadim Yuferov; Peter Zill; Andrew W Bergen; Jingchun Chen; Paul M Cinciripini; Howard J Edenberg; Marissa A Ehringer; Robert E Ferrell; Joel Gelernter; David Goldman; John K Hewitt; Christian J Hopfer; William G Iacono; Jaakko Kaprio; Mary Jeanne Kreek; Ivo M Kremensky; Pamela A F Madden; Matt McGue; Marcus R Munafò; Robert A Philibert; Marcella Rietschel; Alec Roy; Dan Rujescu; Sirkku T Saarikoski; Gary E Swan; Alexandre A Todorov; Michael M Vanyukov; Robert B Weiss; Laura J Bierut; Nancy L Saccone
Journal:  Behav Genet       Date:  2015-09-21       Impact factor: 2.805

Review 5.  Review: Pharmacogenetics of alcoholism treatment: Implications of ethnic diversity.

Authors:  Anita Cservenka; Megan M Yardley; Lara A Ray
Journal:  Am J Addict       Date:  2016-11-04

6.  The OPRM1 A118G polymorphism: converging evidence against associations with alcohol sensitivity and consumption.

Authors:  M E Sloan; T D Klepp; J L Gowin; J E Swan; H Sun; B L Stangl; V A Ramchandani
Journal:  Neuropsychopharmacology       Date:  2018-02-02       Impact factor: 7.853

7.  Independent and Interactive Effects of OPRM1 and DAT1 Polymorphisms on Alcohol Consumption and Subjective Responses in Social Drinkers.

Authors:  Elise M Weerts; Gary S Wand; Brion Maher; Xiaoqiang Xu; Mary Ann Stephens; Xiaoju Yang; Mary E McCaul
Journal:  Alcohol Clin Exp Res       Date:  2017-04-26       Impact factor: 3.455

8.  Pharmacotherapies and personalized medicine for alcohol use disorder: a review.

Authors:  Falk W Lohoff
Journal:  Pharmacogenomics       Date:  2020-08-18       Impact factor: 2.533

9.  Systematic review and meta-analysis of the moderating effect of rs1799971 in OPRM1, the mu-opioid receptor gene, on response to naltrexone treatment of alcohol use disorder.

Authors:  Emily E Hartwell; Richard Feinn; Paige E Morris; Joel Gelernter; John Krystal; Albert J Arias; Michaela Hoffman; Ismene Petrakis; Ralitza Gueorguieva; Joseph P Schacht; David Oslin; Raymond F Anton; Henry R Kranzler
Journal:  Addiction       Date:  2020-02-11       Impact factor: 6.526

Review 10.  Alcoholism and liver disease in Mexico: genetic and environmental factors.

Authors:  Sonia Roman; Eloy Alfonso Zepeda-Carrillo; Laura Eugenia Moreno-Luna; Arturo Panduro
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.